Supriya Lifescience

Sector: Healthcare

Followers

5
5
8
8
.
0
0
4
4
7
7
-10.65 (-1.42%)

As on 01 Jan, 2026 | 15:52

Open Trading A/c
Day Range
735.80
762.00
LH
52 Week Range
556.15
842.00
LH
Volume
* i
Bid / Ask
72,973.00
740.85 / 10.00

Supriya Lifescience Announcements

Intimation on Credit Rating to the Company is enclosed.

30 Dec, 2025 | 03:40pm • Source: BSE

Intimation for Closure of Trading Window for declaration of the Unaudited Financial Results for quarter and nine months ending on December 31, 2025.Kindly take the...

28 Dec, 2025 | 11:36pm • Source: BSE

Transcript of the Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2025, is enclosed herewith.Kindly take the...

18 Nov, 2025 | 10:48am • Source: BSE

Investor Presentation is enclosed herewith.

12 Nov, 2025 | 06:02pm • Source: BSE

Unaudited Financial Results for the Quarter and Half year ended September 30,2025 are enclosed herewith.Kindly take the same on record.

12 Nov, 2025 | 05:25pm • Source: BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the...

12 Nov, 2025 | 05:10pm • Source: BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held...

09 Nov, 2025 | 11:17pm • Source: BSE

Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and...

05 Nov, 2025 | 08:31pm • Source: BSE

Please find enclosed herewith duly signed certificate dated October 7, 2025 issued by MUFG Intime India Pvt. Ltd. our RTA, confirming compliance under Regulation 74(5)...

13 Oct, 2025 | 11:53am • Source: BSE

Completion of WHO GMP audit at Ambernath facility of the Company and receipt of WHO GMP Certificate for Inhalation Dosages.

01 Oct, 2025 | 12:47pm • Source: BSE

The intimation of closure of Trading Window for trading in securities of the Company by Designated Persons and their immediate relatives for the quarter and...

26 Sep, 2025 | 04:46pm • Source: BSE

Brief Proceedings along with Voting Results of 17th AGM is attached herewith.

24 Sep, 2025 | 06:38pm • Source: BSE

Scrutinizers Report for 17th AGM is attached herewith.

24 Sep, 2025 | 06:33pm • Source: BSE

Outcome of AGM along with Proceedings, Scrutinizers Report and Voting Results is attached herewith.

24 Sep, 2025 | 06:31pm • Source: BSE

Details of the Analyst / Institutional Investor Meet scheduled on September 23, 2025 in which the Company shall participate are attached.

17 Sep, 2025 | 04:30pm • Source: BSE

Enclosed herewith is a copy of Newspaper Publication regarding intimation of dispatch of Annual Report, AGM Notice and E-voting Instructions.

02 Sep, 2025 | 02:34pm • Source: BSE

Enclosed herewith is the Letter under Regulation 36 (1) of SEBI (LODR)Regulations, 2015, dispatched by the Company to the Shareholders whose email ids are not...

02 Sep, 2025 | 02:29pm • Source: NSE

Enclosed herewith is the Letter dispatched by the Company to the Shareholders whose email ids are not registered with the Company / Depositories / RTA.Kindly...

02 Sep, 2025 | 02:25pm • Source: BSE

Business Responsibility and Sustainability Report of the Company forming part of Annual Report for FY 2024-25 is enclosed herewith.

01 Sep, 2025 | 07:28pm • Source: BSE

Annual Report of the Company for FY 2024-25 is enclosed herewith.

01 Sep, 2025 | 07:17pm • Source: BSE